Course Information

Cardio-Obstetrics Symposium

Live Virtual Learning

March 12, 2022

Download: [ PDF ]

Cardiovascular disease remains the leading cause of pregnancy-related death in pregnant and postpartum women in the United States, accounting for 26.5% of pregnancy-related deaths. In review by the California Maternal Quality Care Collaborative, 25% of these deaths were felt to have had a strong/good chance to alter the outcome with better management/recognition of disease.

This symposium aims to improve the care of women with known cardiovascular disease, as well as improve recognition of signs and symptoms of cardiac issues in pregnancy, with the goal of decreasing cardiovascular, pregnancy related morbidity and mortality by improving education, and multidisciplinary planning in the care of these complex patients.

Target Audience

  • Adult cardiologists, including all subspecialities (heart failure, ACHD, EP, interventional)
  • Cardiology practice teams: NPs, RNs, sonographers, technicians
  • Cardiac and obstetric anesthesia teams: physicians, CRNA, techs
  • Obstetric teams: MFM, general OB/GYN
  • Obstetric practice teams: RNs, NPs

Course Fees

  • $125 - Physicians
  • $100 - Fellows, Nurses and Allied Health Professionals

Enroll Online

To enroll click here.

Enrollment Deadlines

Note: To ensure course material is received before the course begins, early registration is advised. Online registration will close at 11:59 PM on Wednesday, March 9th.

Enrollment after online registration has closed: Please call (310) 794 – 2620 or email UCLACME@mednet.ucla.edu between 8:00 AM – 5:00 PM (Pacific Standard Time) by Friday, March 11th .

Enrollment on the day(s) of the course: Registration will only be accepted between 7:00 AM - 10:00 AM (Pacific Standard Time). Please email UCLACME@mednet.ucla.edu to enroll.

Refunds

Cancellations must be received in writing by Friday, February 25, 2022 and will be subject to a $50 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided.

Course Chairs
Yalda Afshar, MD, PhD
Co-Director, UCLA Cardio-Obstetrics Program
Assistant Professor
Division of Maternal Fetal Medicine
Department of Obstetrics and Gynecology*

Jeannette Lin, MD
Co-Director, UCLA Cardio-Obstetrics Program
Associate Clinical Professor
Director, ACHD Fellowship Program
Ahmanson/UCLA Adult Congnenital Heart Disease Center*

UCLA Course Faculty
Uri Elkayam, MD
Professor of Medicine
Professor of Obstetrics and Gynecology
Director, Maternal Cardiology
University of Southern California
Keck School of Medicine
Los Angeles, California

Afshan Hameed, MD
Clinical Professor, Obstetrics & Gynecology
Clinical Professor of Cardiology
UCI School of Medicine, Health Sciences
Director, Obstetrical Services; Patient Safety & Quality
University of California, Irvine

Richard W. Hong, MD
FASA Division Chief, Obstetric Anesthesiology
Clinical Professor
Department of Anesthesiology and Perioperative Medicine*

Eliott Main, MD
Clinical Professor
Division of Maternal Fetal Medicine
Department of Obstetrics and Gynecology
Medical Director, California Maternal Quality Care Collaborative
Stanford University School of Medicine

Thalia Mok, MD
Maternal-Fetal Medicine Fellow
Department of Obstetrics and Gynecology*

Jeremy Moore, MD
Associate Professor of Pediatrics
Director, ACHD Electrophysiology
Ahmanson/UCLA Adult Congenital Heart Disease Center

Rajan Saggar MD
Professor of Medicine
Director Pulmonary Hypertension Program
Co-Director, Pulmonary Vascular Disease Program
Lung & Heart-Lung Transplant and Pulmonary Hypertension Programs*

Negeen Shahandeh, MD
Cardiology Fellow*

Aparna Sridhar, MD, MPH, FACOG
Associate Professor
Division of of Family Planning
Department of Obstetrics and Gynecology*

Irving Steinberg, PharmD
Associate Professor
USC Schools Of Pharmacy and Medicine
Associate Dean for Faculty Affairs, School of Pharmacy
Director, Division of Pediatric Pharmacotherapy
University of Southern California

Erica T. Wang, MD, MAS
Associate Professor
Division of Reproductive Endocrinology and Infertility
Department of Obstetrics and Gynecology
Cedars Sinai Medical Center
Los Angeles CA

Jessica Wang, MD, PhD
Assistant Clinical Professor
Department of Cardiology*

Karol Watson, MD, PhD
Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women’s Heart Health Program*

Michael Wolfe, MD
Assistant Clinical Professor
Division of Surgical Critical Care
Department of Anesthesiology and Perioperative Medicine*


*David Geffen School of Medicine, UCLA

Saturday, March 12, 2022

9:00 AM (PST) Welcome and Introduction
Yalda Afshar, MD, PhD and Jeannette Lin, MD

Session I

9:05 AM Cardiac Morbidity and Mortality in Pregnancy
Elliott Main, MD
9:25 AM Hypertensive Disease in Pregnancy and Future Cardiovascular Health
Karol Watson, MD, PhD
9:40 AM Preconception Counseling and Risk Stratification
Jeannette Lin, MD
9:55 AM Fertility Care and Gestational Carriers
Erica T. Wang, MD, MAS
10:10 AM Pharmacology of Cardiac Medication in Pregnancy
Irving Steinberg, MD
10:25 AM Case Presentation: Risk Stratification and Family Planning
Negeen Shahandeh, MD
10:30 AM Panel Discussion
10:40 AM Q&A (Session I)
Session I Speakers
10:50 AM Break

Session II

11:00 AM Arrhythmias in Pregnancy
Jeremy Moore, MD
11:15 AM Heart Failure Management in Pregnancy
Uri Elkayam, MD
11:30 AM Pulmonary Hypertension in Pregnancy
Rajan Saggar, MD
11:45 AM Critically Ill Pregnant Patient in the ICU
Michael Wolfe, MD
12:00 PM Anesthesia Management for the Pregnant Cardiac Patient
Rich Hong, MD
12:15 PM Labor Management and Delivery in Cardiac Patient
Yalda Afshar, MD, PhD
12:30 PM Break
1:00 PM Case Presentation: Delivery Planning
Thalia Mok, MD
1:05 PM Panel Discussion
1:15 PM Q&A (Session II)
Session II Speakers

Session III

1:25 PM Keynote: Screening Toolkit for CV Risk in Pregnancy
Afshan Hameed, MD
1:55 PM Contraception and Family Planning
Aparna Sridhar, MD, MPH
2:05 PM Genetic Testing and Couseling with Cardiac Disease
Jessica Wang, MD, PhD
2:15 PM Q&A (Session III)
2:25 PM Wrap Up and Adjourn
Yalda Afshar, MD, PhD and Jeannette Lin, MD

At the conclusion of this course, participants will be able to:

  • Identify hemodynamic changes in pregnancy, and their impact in cardiac patients
  • Learn about management of known cardiovascular conditions in pregnancy
  • Understand cardiovascular complications of pregnancy, and their short and long term ramifications for cardiovascular health
  • Recognize the importance of a multidisciplinary team in management of cardio-obstetric patients
  • Learn about peripartum management, including anesthesia management, and management of delivery complications
  • Identify tools for contraception management, counseling re: termination, genetic counseling, and fertility treatments
  • Learn about management of the critically ill pregnant cardiac patient

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 5 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved by the AMA for category 1 credit as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.